Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
29 studies found for:    "Bacterial Infections" | Mexico
Show Display Options
Rank Status Study
1 Completed
Has Results
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
2 Completed BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Condition: Bacterial Infections
Interventions: Drug: Ciprofloxacin single dose;   Drug: Ciprofloxacin triple dose
3 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: ceftaroline;   Drug: vancomycin plus aztreonam;   Drug: Placebo
4 Completed
Has Results
TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA;   Drug: Linezolid
5 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: IV Vancomycin plus IV Aztreonam;   Drug: Ceftaroline
6 Completed
Has Results
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
Conditions: Bacterial Infections;   Intra-Abdominal Infection;   Pneumonia, Bacterial;   Skin Diseases, Bacterial;   Skin Diseases, Infectious
Intervention: Drug: Tygacil
7 Completed
Has Results
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
Condition: Musculoskeletal Diseases
Intervention: Drug: No intervention
8 Recruiting Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: rMenB+OMV  and MenACWY;   Biological: rMenB+OMV;   Biological: MenACWY
9 Completed
Has Results
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
Condition: Methicillin Resistant Staphylococcus Aureus (MRSA)
Interventions: Drug: linezolid (Zyvox);   Drug: vancomycin
10 Completed
Has Results
13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico
Condition: Pneumococcal Infections
Intervention: Biological: vaccine-13vPnC
11 Completed Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™
Condition: Infections, Streptococcal
Interventions: Biological: Synflorix™ (3-Dose);   Biological: Synflorix™ (2-Dose);   Biological: Synflorix™ (Single Dose);   Biological: Prevenar 13 ™ (Single Dose);   Biological: Prevenar 13 ™ (2-Dose)
12 Completed
Has Results
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
Conditions: Skin/Soft Tissue Infections;   Methicillin Resistant Staphylococcus Aureus (MRSA)
Interventions: Drug: linezolid;   Drug: vancomycin
13 Completed Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration
Conditions: Meningococcal Disease;   Pneumococcal Disease.
Interventions: Biological: Meningococcal vaccine GSK134612;   Biological: Pneumococcal vaccine GSK1024850A
14 Completed
Has Results
Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.
Conditions: Meningococcal Infection;   Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine;   Haemophilus Influenza b Infections
Interventions: Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014);   Biological: PedvaxHIB;   Biological: Prevnar;   Biological: M-M-R II;   Biological: Varivax
15 Unknown  Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
16 Completed Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment
Condition: Impetigo
Intervention: Drug: SB-275833 ointment, 1%
17 Active, not recruiting Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
Conditions: Human Immunodeficiency Virus (HIV);   Tuberculosis (TB);   Latent Tuberculosis Infection (LTI)
Intervention: Drug: Isoniazid
18 Recruiting Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Inhalation Solution (BAY41-6551);   Drug: Aerosolized Placebo
19 Terminated
Has Results
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-Acquired Infections;   Nosocomial Infection;   Pneumonia, Ventilator-Associated
Interventions: Drug: Cefepime placebo;   Drug: Cefepime;   Drug: Doripenem;   Drug: Doripenem placebo;   Drug: Amoxicillin/clavulanate potassium
20 Completed Expression of Tuberculosis in the Lung
Condition: Tuberculosis
Intervention: Other: Bronchoalveolar lavages and venipunctures only

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Indicates status has not been verified in more than two years